PulseAugur
EN
LIVE 13:20:00
中文(ZH) 亚太药业:全资子公司拟3000万元认购投资基金份额

亚太药业 invests 30M yuan in healthcare fund; Junshi Electronics eyes optical module market

亚太药业's wholly-owned subsidiary, Zhejiang Yatai Lizhong Holdings Co., Ltd., plans to invest 30 million yuan to subscribe for additional shares in the Jiaxing Yuyan Equity Investment Partnership (Limited Partnership). This investment, representing 30% of the fund's total committed capital, will be allocated to high-quality unlisted equity assets and non-publicly traded securities of listed companies within the healthcare industry, focusing on areas such as pharmaceutical R&D, production, services, and innovative technologies. Additionally, the cluster mentions Junshi Electronics' positive outlook on the optical module market through its investee company, Xinfeiguang Communication Technology Co., Ltd., which has entered mass production for its optical modules. AI

RANK_REASON The cluster reports on a significant investment by a company subsidiary into a healthcare-focused investment fund, alongside news of another company's progress in the optical module market. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Asia-Pacific Pharmaceutical: Wholly-owned subsidiary plans to subscribe for fund investment shares worth 30 million yuan

    36氪获悉,亚太药业公告,全资子公司浙江雅泰利众控股有限公司作为有限合伙人,拟以自有资金出资3000万元认购嘉兴雨燕股权投资合伙企业(有限合伙)(简称“投资基金”)的基金扩募份额,占其认缴出资总额的30%。该投资基金将投资于医药研发、生产、服务及创新技术等大健康产业领域优质的未上市公司股权、已上市公司的非公开交易证券等股权类资产。